Barbagallo et al. (29) investigate the impact of LDL receptor (LDLR) mutations on glycemic status and atherosclerosis in familial hypercholesterolemia (FH), finding that LDLR-null individuals have worse glycemic control and more severe coronary artery calcification (CAC). This evidence concerns the gene LDLR and familial hyperaldosteronism.